Pfizer recalls 28 lots of contraceptive pill in US
This article was originally published in Scrip
Pfizer has voluntarily recalled 14 lots of Lo/Ovral-28 (norgestrel and ethinyl estradiol) Tablets and 14 lots of the generic version of the same drug in the US, following an investigation which revealed that some blister packs may contain an inexact count of inert or active ingredients and that tablets may be out of sequence. The blister packs are supposed to contain 21 tablets of active ingredient and seven inert ones, and errors in the daily dosing leave women without adequate contraception and at risk of unplanned pregnancy. Patients using the affected products are recommended to notify their physician, return the product to the pharmacy and report any adverse events or side effects.